Antidepressant prescribing in transgender and nonbinary individuals diagnosed with gender dysphoria and mood or anxiety disorders
Descripción general
Resumen del artículo
This retrospective, single-center study found that 38% of transgender and nonbinary (TGNB) adults diagnosed with gender dysphoria and co-occurring mood or anxiety disorders did not have an active antidepressant prescription at the time of their gender dysphoria diagnosis. While antidepressant prescribing rates were similar across gender identities, transgender females were more often prescribed bupropion, and transgender males had significantly higher rates of generalized anxiety disorder. This highlights a potential gap in mental health care for TGNB adults and warrants further investigation.
Explícamelo como si tuviera cinco años
Many transgender and nonbinary adults who feel sad or worried and also have gender dysphoria aren't getting help from antidepressant medicines, suggesting a gap in their mental health care. This study found over a third of them were not prescribed these medications.
Posibles conflictos de intereses
None identified
Limitaciones identificadas
Explicación de la calificación
This exploratory, retrospective single-center study provides valuable initial insights into antidepressant prescribing patterns in transgender and nonbinary individuals. While it identified a significant potential gap in mental health care, its methodology has several limitations, including its retrospective nature, single-center design, and inability to account for confounding factors like gender-affirming care, which reduce the generalizability and causal inference of its findings.
Conviene saber
Este es el análisis de Starter. Paperzilla Pro verifica cada cita, investiga los antecedentes de los autores y las fuentes de financiación, y utiliza razonamiento avanzado con IA para ofrecer información más exhaustiva.
Explorar Pro →